Next听generation听sequencing听(NGS) has created a noteworthy paradigm shift in the clinical diagnostic field. It refers to an aggregate collection of methods in which various听sequencing听reactions occur at the same time, bringing about vast amounts of听sequencing听data for a little division of the cost of Sanger听sequencing.
The global market for Next-Generation Sequencing Data Analysis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Next-Generation Sequencing Data Analysis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next-Generation Sequencing Data Analysis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Next-Generation Sequencing Data Analysis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Next-Generation Sequencing Data Analysis include Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PierianDx, Intrexon Bioinformatics Germany GmbH and Partek, Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Next-Generation Sequencing Data Analysis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Next-Generation Sequencing Data Analysis by region & country, by Type, and by Application.
The Next-Generation Sequencing Data Analysis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Sequencing Data Analysis.
麻豆原创 Segmentation
By Company
Thermo Fisher Scientific, Inc.
QIAGEN
Illumina, Inc.
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
PierianDx
Intrexon Bioinformatics Germany GmbH
Partek, Inc.
Eurofins Scientific
Pacific Biosciences of California, Inc.
DNASTAR, Inc.
Congenica Ltd.
Fabric Genomics, Inc.
Genuity Science
DNAnexus Inc.
SciGenom Labs Pvt. Ltd.
Golden Helix, Inc.
The Beijing Genomics Institute
LifeTech
Berry Genomics
Da An Gene
Segment by Type:
In-house
Outsourced
Segment by Application
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other Users
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Next-Generation Sequencing Data Analysis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Next-Generation Sequencing Data Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Next-Generation Sequencing Data Analysis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Next-Generation Sequencing Data Analysis Product Introduction
1.2 Global Next-Generation Sequencing Data Analysis 麻豆原创 Size Forecast
1.3 Next-Generation Sequencing Data Analysis 麻豆原创 Trends & Drivers
1.3.1 Next-Generation Sequencing Data Analysis Industry Trends
1.3.2 Next-Generation Sequencing Data Analysis 麻豆原创 Drivers & Opportunity
1.3.3 Next-Generation Sequencing Data Analysis 麻豆原创 Challenges
1.3.4 Next-Generation Sequencing Data Analysis 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Next-Generation Sequencing Data Analysis Players Revenue Ranking (2023)
2.2 Global Next-Generation Sequencing Data Analysis Revenue by Company (2019-2024)
2.3 Key Companies Next-Generation Sequencing Data Analysis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Next-Generation Sequencing Data Analysis Product Offered
2.5 Key Companies Time to Begin Mass Production of Next-Generation Sequencing Data Analysis
2.6 Next-Generation Sequencing Data Analysis 麻豆原创 Competitive Analysis
2.6.1 Next-Generation Sequencing Data Analysis 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Next-Generation Sequencing Data Analysis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Sequencing Data Analysis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 In-house
3.1.2 Outsourced
3.2 Global Next-Generation Sequencing Data Analysis Sales Value by Type
3.2.1 Global Next-Generation Sequencing Data Analysis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Next-Generation Sequencing Data Analysis Sales Value, by Type (2019-2030)
3.2.3 Global Next-Generation Sequencing Data Analysis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Academic Research
4.1.2 Clinical Research
4.1.3 Hospitals & Clinics
4.1.4 Pharma & Biotech Entities
4.1.5 Other Users
4.2 Global Next-Generation Sequencing Data Analysis Sales Value by Application
4.2.1 Global Next-Generation Sequencing Data Analysis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Next-Generation Sequencing Data Analysis Sales Value, by Application (2019-2030)
4.2.3 Global Next-Generation Sequencing Data Analysis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Next-Generation Sequencing Data Analysis Sales Value by Region
5.1.1 Global Next-Generation Sequencing Data Analysis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Next-Generation Sequencing Data Analysis Sales Value by Region (2019-2024)
5.1.3 Global Next-Generation Sequencing Data Analysis Sales Value by Region (2025-2030)
5.1.4 Global Next-Generation Sequencing Data Analysis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
5.2.2 North America Next-Generation Sequencing Data Analysis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
5.3.2 Europe Next-Generation Sequencing Data Analysis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
5.4.2 Asia Pacific Next-Generation Sequencing Data Analysis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
5.5.2 South America Next-Generation Sequencing Data Analysis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
5.6.2 Middle East & Africa Next-Generation Sequencing Data Analysis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Next-Generation Sequencing Data Analysis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Next-Generation Sequencing Data Analysis Sales Value
6.3 United States
6.3.1 United States Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
6.3.2 United States Next-Generation Sequencing Data Analysis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Next-Generation Sequencing Data Analysis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
6.4.2 Europe Next-Generation Sequencing Data Analysis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Next-Generation Sequencing Data Analysis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
6.5.2 China Next-Generation Sequencing Data Analysis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Next-Generation Sequencing Data Analysis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
6.6.2 Japan Next-Generation Sequencing Data Analysis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Next-Generation Sequencing Data Analysis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
6.7.2 South Korea Next-Generation Sequencing Data Analysis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Next-Generation Sequencing Data Analysis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
6.8.2 Southeast Asia Next-Generation Sequencing Data Analysis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Next-Generation Sequencing Data Analysis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Next-Generation Sequencing Data Analysis Sales Value, 2019-2030
6.9.2 India Next-Generation Sequencing Data Analysis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Next-Generation Sequencing Data Analysis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Thermo Fisher Scientific, Inc. Profile
7.1.2 Thermo Fisher Scientific, Inc. Main Business
7.1.3 Thermo Fisher Scientific, Inc. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.1.4 Thermo Fisher Scientific, Inc. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific, Inc. Recent Developments
7.2 QIAGEN
7.2.1 QIAGEN Profile
7.2.2 QIAGEN Main Business
7.2.3 QIAGEN Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.2.4 QIAGEN Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.2.5 QIAGEN Recent Developments
7.3 Illumina, Inc.
7.3.1 Illumina, Inc. Profile
7.3.2 Illumina, Inc. Main Business
7.3.3 Illumina, Inc. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.3.4 Illumina, Inc. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Profile
7.4.2 F. Hoffmann-La Roche Ltd. Main Business
7.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.4.4 F. Hoffmann-La Roche Ltd. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.4.5 F. Hoffmann-La Roche Ltd. Recent Developments
7.5 Agilent Technologies, Inc.
7.5.1 Agilent Technologies, Inc. Profile
7.5.2 Agilent Technologies, Inc. Main Business
7.5.3 Agilent Technologies, Inc. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.5.4 Agilent Technologies, Inc. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.5.5 Agilent Technologies, Inc. Recent Developments
7.6 Bio-Rad Laboratories, Inc.
7.6.1 Bio-Rad Laboratories, Inc. Profile
7.6.2 Bio-Rad Laboratories, Inc. Main Business
7.6.3 Bio-Rad Laboratories, Inc. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.6.4 Bio-Rad Laboratories, Inc. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.6.5 Bio-Rad Laboratories, Inc. Recent Developments
7.7 PierianDx
7.7.1 PierianDx Profile
7.7.2 PierianDx Main Business
7.7.3 PierianDx Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.7.4 PierianDx Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.7.5 PierianDx Recent Developments
7.8 Intrexon Bioinformatics Germany GmbH
7.8.1 Intrexon Bioinformatics Germany GmbH Profile
7.8.2 Intrexon Bioinformatics Germany GmbH Main Business
7.8.3 Intrexon Bioinformatics Germany GmbH Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.8.4 Intrexon Bioinformatics Germany GmbH Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.8.5 Intrexon Bioinformatics Germany GmbH Recent Developments
7.9 Partek, Inc.
7.9.1 Partek, Inc. Profile
7.9.2 Partek, Inc. Main Business
7.9.3 Partek, Inc. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.9.4 Partek, Inc. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.9.5 Partek, Inc. Recent Developments
7.10 Eurofins Scientific
7.10.1 Eurofins Scientific Profile
7.10.2 Eurofins Scientific Main Business
7.10.3 Eurofins Scientific Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.10.4 Eurofins Scientific Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.10.5 Eurofins Scientific Recent Developments
7.11 Pacific Biosciences of California, Inc.
7.11.1 Pacific Biosciences of California, Inc. Profile
7.11.2 Pacific Biosciences of California, Inc. Main Business
7.11.3 Pacific Biosciences of California, Inc. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.11.4 Pacific Biosciences of California, Inc. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.11.5 Pacific Biosciences of California, Inc. Recent Developments
7.12 DNASTAR, Inc.
7.12.1 DNASTAR, Inc. Profile
7.12.2 DNASTAR, Inc. Main Business
7.12.3 DNASTAR, Inc. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.12.4 DNASTAR, Inc. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.12.5 DNASTAR, Inc. Recent Developments
7.13 Congenica Ltd.
7.13.1 Congenica Ltd. Profile
7.13.2 Congenica Ltd. Main Business
7.13.3 Congenica Ltd. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.13.4 Congenica Ltd. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.13.5 Congenica Ltd. Recent Developments
7.14 Fabric Genomics, Inc.
7.14.1 Fabric Genomics, Inc. Profile
7.14.2 Fabric Genomics, Inc. Main Business
7.14.3 Fabric Genomics, Inc. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.14.4 Fabric Genomics, Inc. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.14.5 Fabric Genomics, Inc. Recent Developments
7.15 Genuity Science
7.15.1 Genuity Science Profile
7.15.2 Genuity Science Main Business
7.15.3 Genuity Science Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.15.4 Genuity Science Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.15.5 Genuity Science Recent Developments
7.16 DNAnexus Inc.
7.16.1 DNAnexus Inc. Profile
7.16.2 DNAnexus Inc. Main Business
7.16.3 DNAnexus Inc. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.16.4 DNAnexus Inc. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.16.5 DNAnexus Inc. Recent Developments
7.17 SciGenom Labs Pvt. Ltd.
7.17.1 SciGenom Labs Pvt. Ltd. Profile
7.17.2 SciGenom Labs Pvt. Ltd. Main Business
7.17.3 SciGenom Labs Pvt. Ltd. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.17.4 SciGenom Labs Pvt. Ltd. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.17.5 SciGenom Labs Pvt. Ltd. Recent Developments
7.18 Golden Helix, Inc.
7.18.1 Golden Helix, Inc. Profile
7.18.2 Golden Helix, Inc. Main Business
7.18.3 Golden Helix, Inc. Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.18.4 Golden Helix, Inc. Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.18.5 Golden Helix, Inc. Recent Developments
7.19 The Beijing Genomics Institute
7.19.1 The Beijing Genomics Institute Profile
7.19.2 The Beijing Genomics Institute Main Business
7.19.3 The Beijing Genomics Institute Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.19.4 The Beijing Genomics Institute Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.19.5 The Beijing Genomics Institute Recent Developments
7.20 LifeTech
7.20.1 LifeTech Profile
7.20.2 LifeTech Main Business
7.20.3 LifeTech Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.20.4 LifeTech Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.20.5 LifeTech Recent Developments
7.21 Berry Genomics
7.21.1 Berry Genomics Profile
7.21.2 Berry Genomics Main Business
7.21.3 Berry Genomics Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.21.4 Berry Genomics Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.21.5 Berry Genomics Recent Developments
7.22 Da An Gene
7.22.1 Da An Gene Profile
7.22.2 Da An Gene Main Business
7.22.3 Da An Gene Next-Generation Sequencing Data Analysis Products, Services and Solutions
7.22.4 Da An Gene Next-Generation Sequencing Data Analysis Revenue (US$ Million) & (2019-2024)
7.22.5 Da An Gene Recent Developments
8 Industry Chain Analysis
8.1 Next-Generation Sequencing Data Analysis Industrial Chain
8.2 Next-Generation Sequencing Data Analysis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Next-Generation Sequencing Data Analysis Sales Model
8.5.2 Sales Channel
8.5.3 Next-Generation Sequencing Data Analysis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Thermo Fisher Scientific, Inc.
QIAGEN
Illumina, Inc.
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
PierianDx
Intrexon Bioinformatics Germany GmbH
Partek, Inc.
Eurofins Scientific
Pacific Biosciences of California, Inc.
DNASTAR, Inc.
Congenica Ltd.
Fabric Genomics, Inc.
Genuity Science
DNAnexus Inc.
SciGenom Labs Pvt. Ltd.
Golden Helix, Inc.
The Beijing Genomics Institute
LifeTech
Berry Genomics
Da An Gene
听
听
*If Applicable.